Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald R. Blanck currently holds 6,062 shares of TENAX THERAPEUTICS, INC. (TENX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald R. Blanck has been a net buyer of TENX stock. They have purchased $39.0K and sold $5.1K worth of shares.
Ronald R. Blanck's most recent insider trade was on May 18, 2020, when they purchased 5,000 shares at $0.95 per share.
Ronald R. Blanck serves as Executive at TENAX THERAPEUTICS, INC. (TENX). They have executed 12 insider transactions totaling $44.1K over their tenure at the company.
Ronald R. Blanck holds the position of Executive at TENAX THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Ronald R. Blanck has shown a buying trading pattern, with $39.0K in total purchases and $5.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ronald R. Blanck was on May 1, 2012, when they purchased $33.8K worth of OXBT shares. This transaction involved 18,961 shares at $1.78 per share.
Ronald R. Blanck currently owns 6,062 shares of TENAX THERAPEUTICS, INC. (TENX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald R. Blanck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald R. Blanck has 12 Form 4 filings on record as an insider at TENAX THERAPEUTICS, INC..
Set alerts for Ronald R. Blanck and 40,000+ other insiders.